OOIR: Observatory of International Research

Papers

(The TQCC of Hamostaseologie is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH	143
Coagulopathy in COVID-19 and Its Implication for Safe and Efficacious Thromboprophylaxis	67
Factor XI as a Target for New Anticoagulants	46
Platelets and COVID-19	46
Platelet Shape Changes during Thrombus Formation: Role of Actin-Based Protrusions	26
Head, Neck, and Abdominopelvic Septic Thrombophlebitis: Current Evidence and Challenges in Diagnosis and Treatment	26
Acquired von Willebrand Syndrome and Platelet Function Defects during Extracorporeal Life Support (Mechanical Circulatory Support)	24
Prevention of Venous Thromboembolism during Pregnancy and the Puerperium with a Special Focus on Women with Hereditary Thrombophilia or Prior VTE—Position Paper of the Working Group in Women's Health	23
Platelet Purinergic Receptors in Thrombosis and Inflammation	22
Navigating the Myriad of von Willebrand Factor Assays	20
Ovarian Vein Thrombosis: A Narrative Review	19
Platelets in Thrombo-Inflammation: Concepts, Mechanisms, and Therapeutic Strategies for Ischemic Stroke	19
Practical Guidance of the GTH Haemophilia Board on the Use of Emicizumab in Patients with Haemophilia A	19
Does One Dose Really Fit All? On the Monitoring of Direct Oral Anticoagulants: A Review of the Literature	19
Thrombophilia, Thrombosis and Thromboprophylaxis in Pregnancy: For What and in Whom?	18
Erratum: Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH	17
Management of Disseminated Intravascular Coagulation in Acute Leukemias	15
Procoagulant Platelets: Mechanisms of Generation and Action	15
Effects and Side Effects of Platelet Transfusion	13
The Evolution of Hemophilia Care: Clinical and Laboratory Advances, Opportunities, and Challenges	13
COVID-19 and Cardiac Arrhythmias	12
Childhood Arterial Ischaemic Stroke: Clinical Presentation, Risk Factors and Management	12
Use of Anticoagulants in Patients with Pulmonary Hypertension	11
Anti-inflammatory Strategies in Atherosclerosis	11
Challenges in Detecting Clinically Relevant Heparin-Induced Thrombocytopenia Antibodies	11

Prevention and Management of Thrombosis in BCR/ABL-Negative Myeloproliferative Neoplasms	11
Screening for Occult Cancer in Patients with Venous Thromboembolism: Past, Present, and Future	10
COVID-19 Coagulopathy with Superior Mesenteric Vein Thrombosis Complicated by an Ischaemic Bowel	10
Role of Platelet Cytoskeleton in Platelet Biomechanics: Current and Emerging Methodologies and Their Potential Relevance for the Investigation of Inherited Platelet Disorders	10
Understanding and Preventing Placenta-Mediated Pregnancy Complications	10
Insights into the Molecular Genetic of Hemophilia A and Hemophilia B: The Relevance of Genetic Testing in Routine Clinical Practice	10
Trauma-Induced Coagulopathy and Massive Bleeding: Current Hemostatic Concepts and Treatment Strategies	9
From Routine to Research Laboratory: Strategies for the Diagnosis of Congenital Fibrinogen Disorders	9
COVID-19 and Myocarditis: Findings from Cardiac Magnetic Resonance Imaging and Endomyocardial Biopsies	9
In Silico Hemostasis Modeling and Prediction	8
New Developments in the Pathophysiology and Management of Primary Immune Thrombocytopenia	8
A Review of FXIa Inhibition as a Novel Target for Anticoagulation	8
Functional Roles of the von Willebrand Factor Propeptide	8
Consensus Recommendations for Intramuscular COVID-19 Vaccination in Patients with Hemophilia	8
Usefulness of Thrombin Generation	7
When and How to Combine Antiplatelet and Anticoagulant Drugs?	7
Pulmonary Hypertension and COVID-19	7
Bleeding Risk Assessment in Patients with Venous Thromboembolism	7
Current and Future Perspectives on ADAMTS13 and Thrombotic Thrombocytopenic Purpura	7
Cardiac and Cerebral Arterial Complications of Lemierre Syndrome: Results from a Systematic Review and Individual Patient Data Meta-analysis	7
Fine-Tuning of Platelet Responses by Serine/Threonine Protein Kinases and Phosphatases—Just the Beginning	7
An Update on Laboratory Diagnostics in Haemophilia A and B	7
What about Platelet Function in Platelet Concentrates?	7
How to Differentiate Recurrent Deep Vein Thrombosis from Postthrombotic Syndrome	7
Management of Antithrombin Deficiency in Pregnancy	7
Molecular Profiling of Liver Sinusoidal Endothelial Cells in Comparison to Hepatocytes: Reflection on Which Cell Type Should Be the Target for Gene Therapy	7
Anticoagulation in Critically Ill Adults during Extracorporeal Circulation	7
Laboratory Techniques Used to Diagnose Constitutional Platelet Dysfunction	6
Extended Half-Life Factor VIII/Factor IX Products: Assay Discrepancies and Implications for Hemophilia Management	6
Microvascular Skin Manifestations Caused by COVID-19	6
COVID-19 and the Incidence of Acute Myocardial Injury	6
Measuring Fibrinolysis	6
Pathophysiology of the Venous Thromboembolism Risk in Preeclampsia	6
Can We Measure the Individual Prothrombotic or Prohemorrhagic Tendency by Global Coagulation Tests?	6
Perinatal Management of Haemophilia	6
Venous Thrombosis and SARS-CoV-2	6
Mechanism, Functions, and Diagnostic Relevance of FXII Activation by Foreign Surfaces	6
Diagnosis of Platelet Function Disorders: A Challenge for Laboratories	5
How to Capture the Bleeding Phenotype in FXI-Deficient Patients	5
Critical Bleeding in Acquired Hemophilia A: Bypassing Agents or Recombinant Porcine Factor VIII?	5
Anticoagulation Therapy in Cancer Patients with Thrombosis in the Outpatient Sector of Germany (The CERTIFICAT Initiative)—German Practice of Anticoagulation Therapy of Cancer Patients with Thrombosis	5
Platelets and Matrix Metalloproteinases: A Bidirectional Interaction with Multiple Pathophysiologic Implications	5
How the COVID-19 Pandemic Impacts Lives of Life Scientists	5
How Do I Reverse Oral and Parenteral Anticoagulants?	5
Anticoagulation in Pediatric Patients	5
Bleeding Issues in Women Under Oral Anticoagulation	5
Emicizumab for All Pediatric Patients with Severe Hemophilia A	5
Screening for Cancer in Patients with Acute Venous Thromboembolic Disease	4
Insights from the Hereditary Thrombotic Thrombocytopenic Purpura Registry: Discussion of Key Findings Based on Individual Cases from Switzerland	4
Flow Cytometric Assessment of AKT Signaling in Platelet Activation: An Alternative Diagnostic Tool for Small Volumes of Blood	4

Translating Laboratory Tests into Clinical Practice: A Conceptual Framework	4
Prevention of Pregnancy Complications in Antiphospholipid Syndrome	4
Interventional Treatment Options in Children with Extracranial Vascular Malformations	4
Do miRNAs Have a Role in Platelet Function Regulation?	4
Laboratory Assessment of Coagulation Factor XIII	4
Thromboinflammation as a Driver of Venous Thromboembolism	4